Vyepti Side Effects
Generic name: eptinezumab
Note: This document contains side effect information about eptinezumab. Some of the dosage forms listed on this page may not apply to the brand name Vyepti.
For the Consumer
Applies to eptinezumab: intravenous solution
Side effects requiring immediate medical attention
Along with its needed effects, eptinezumab (the active ingredient contained in Vyepti) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking eptinezumab:
Less common
- Chest tightness
- fast heartbeat
- feeling of warmth
- fever
- hives, itching, skin rash
- hoarseness
- irritation
- joint pain, stiffness or swelling
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs
- redness of the skin
- redness of the face, neck, arms and occasionally, upper chest
- swelling of the eyelids, face, lips, hands, or feet
- trouble breathing or swallowing
Incidence not known
- Cough
- dizziness
- unusual tiredness or weakness
Side effects not requiring immediate medical attention
Some side effects of eptinezumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
More common
- Headache
- muscle aches
- sore throat
- stuffy or runny nose
Incidence not known
- Bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
For Healthcare Professionals
Applies to eptinezumab: intravenous solution
General
The most commonly reported adverse reactions have been nasopharyngitis and hypersensitivity.[Ref]
Hypersensitivity
Common (1% to 10%): Hypersensitivity
Frequency not reported: Anaphylactic reactions
Hypersensitivity reactions included terms, such as hypersensitivity, pruritus, and flushing/hot flush, occurring on the day of dosing. Hypersensitivity was reported in up to 3% and up to 4% of patients receiving doses of 100 mg or 300 mg, respectively
Respiratory
Common (1% to 10%): Nasopharyngitis
Frequently asked questions
- What are the new drugs for the treatment of migraines?
- How long does it take Vyepti to work?
- Does Vyepti cause weight gain?
- How long do Vyepti infusions take?
- Can Vyepti cause fatigue?
- How is Vyepti different from Aimovig?
More about Vyepti (eptinezumab)
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (11)
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: CGRP inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
References
1. "Product Information. Vyepti (eptinezumab)." Lundbeck Inc (2020):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.